email
register here
password
new password
privacy policy
|
imprint | copyright
search
analysis
Meta-analyses-DataBase
2603 publications
< back to search
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.
Baeten [I], Dominique Sieper, Joachim Braun, Jurgen Baraliakos, Xenofon Dougados, Maxime Emery, Paul Deodhar, Atul Porter, Brian Martin, Ruvie Andersson, Mats Mpofu, Shephard Richards, Hanno B
published in:
The New England journal of medicine
abstract
endpoint
Sekukinumab has (optional: compared with placebo) proved to be better.
general condition better
basics
diagnosis:
ankylosing spondylitis
localization:
not specified
method:
conservative therapy → injection
conservative therapy → injection therapy
publication details
DOI
10.1056/NEJMoa1505066
exernal index
26699169
year of publication
2015
publication type
randomized controlled trial
multicenter
yes
view
prospective
level of evidence
1+
▼
▲